References
- Bast RC, Jr, Klug T L, John E S, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983; 309: 883–7
- Brioschi P A, Irion O, Bischof P, Bader M, Forni M, Krauer F. Serum CA 125 in epithelial ovarian cancer. A longitudinal study. Br J Obstet Gynecol 1987; 4: 196–201
- Einhorn N., Bast RC, Jr, Knapp RC, Tjernberg B, Zurawski VR, Jr. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet Gynecol 1986; 67: 414–6
- O'Connell G J, Ryan E, Murphy K J, Prefontaine M. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses. Obstet Gynecol 1987; 70: 930–2
- Kabawat S E, Bast RC, Jr, Bhan A K, Welch W R, Knapp R C, Colvin RB. Tissue distribution of a coelomic epithelium-related antigen recognized by the monoclonal antibody OC 125. Int J Gynecol Pathol 1983; 2: 275–85
- Halila H, Stenman U H, Seppala M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer 1986; 57: 1327–9
- Ruibal A, Encabo G, Martinez-Miralles E, et al. CA 125 serum levels in non malignant pathologies. Bull Cancer (Paris) 1984; 71: 145–8